Role of arformoterol in the management of COPD
Paul KingMonash University Department of Medicine and Department of Respiratory and Sleep Medicine, Monash Medical Centre, AustraliaAbstract: Formoterol is a beta2-agonist that has both short and long acting bronchodilator effects. Βeta2-agonists used as bronchodilators have been synthe...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-10-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/role-of-arformoterol-in-the-management-of-copd-a2450 |